|Articles|April 30, 2021
SEC Separation of ADC Brentuximab Vedotin
Author(s)YMC Europe GmbH
The antibody-drug conjugate was separated from its aggregates and fragments in only one run using a YMC-SEC MAB column and varying mobile phases.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Subscribe